Compare PLSE & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | ERII |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 400.7M |
| IPO Year | 2015 | 2008 |
| Metric | PLSE | ERII |
|---|---|---|
| Price | $51.75 | $6.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $22.00 | $17.07 |
| AVG Volume (30 Days) | 612.2K | ★ 933.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $134,987,000.00 |
| Revenue This Year | $840.00 | N/A |
| Revenue Next Year | $287.54 | $20.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $6.69 |
| 52 Week High | $58.90 | $18.31 |
| Indicator | PLSE | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 33.70 |
| Support Level | $49.01 | N/A |
| Resistance Level | $58.90 | $11.58 |
| Average True Range (ATR) | 4.59 | 0.23 |
| MACD | -0.70 | -0.02 |
| Stochastic Oscillator | 35.18 | 15.45 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.